The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Novartis, AstraZeneca, Lilly, Pfizer, Daiichi Sankyo, MSD (Merck Sharp&Dome), Roche, Seagen, Exact Sciences, Gilaed, Istituto Gentili
Comparison of antitumor efficacy of first-line palbociclib, ribociclib, or abemaciclib in patients with HR+/HER2- aBC: Results of the multicenter, real-world, Italian study PALMARES-2.
 
Claudio Vernieri
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Novartis; Pfizer
Speakers' Bureau - Accademia Nazionale Di Medicina (ACCMED); Istituto Gentili; Lilly; Novartis
Research Funding - Roche
 
Leonardo Provenzano
No Relationships to Disclose
 
Mario Giuliano
Honoraria - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca, Daichii Sankyo, Eisai, Exact Sciences, Gilead, Lilly, Menarini Stemline, MSD, Novartis, Pfizer, Roche, Seagen
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Lilly, Pfizer, AstraZeneca
 
Gianpiero Rizzo
No Relationships to Disclose
 
Angela Toss
Honoraria - AstraZeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; Seagen
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; MSD/AstraZeneca; Novartis; Pfizer; Seagen
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Gilead Sciences
 
Marta Piras
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Marianna Sirico
No Relationships to Disclose
 
Barbara Tagliaferri
Honoraria - Novartis, Daichii-Sankyo, Lilly. Travel grants from Pfizer, Novartis, Daichii-Sankyo, Gentili
 
Monica Giordano
No Relationships to Disclose
 
Daniela Miliziano
No Relationships to Disclose
 
Daniele Giulio Generali
Honoraria - Novartis, Lilly, Pfizer, Daiichy-Sankyo, Roche
Research Funding - Astrazeneca, Novartis, LILT
 
Donata Sartori
No Relationships to Disclose
 
Alberto Zambelli
No Relationships to Disclose
 
Alessandra Gennari
Honoraria - Daiichi Sankyo Europe GmbH; Eisai Europe; Gilead Sciences; Lilly; Novartis; Roche
Speakers' Bureau - Eisai Europe
 
Nicla Maria La Verde
Consulting or Advisory Role - Novartis, Pfizer, Roche, MSD, Astrazeneca, EISAI
Speakers' Bureau - Pfizer, Roche, Gentili, Lilly, Gilead, Daiichi Sankyo, Techdow
Research Funding - GSK, Gilead (Inst)
Travel, Accommodations, Expenses - Pfizer, Roche
 
Rebecca Pedersini
No Relationships to Disclose
 
Matteo Lambertini
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Ipsen; Knight Therapeutics; Libbs; Lilly; Menarini; Novartis; Pfizer; Roche; Sandoz; Takeda
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Gilead Sciences; Roche
 
Andrea Botticelli
Consulting or Advisory Role - Roche, MSD, Novartis, Pfizer, Lilly, Amgen, BMS, Gliead, Sofos, Daichii, AstraZeneca
 
Giuseppe Curigliano
Leadership - ESMO; ESMO Open; European Society of Breast Cancer Specialists (EUSOMA=
Honoraria - Ellipses Pharma
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Celcuity; Daichi-Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; GlaxoSmithKline; Guardant Health; Hengrui Therapeutics; Lilly; Menarini; Merck; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen; Veracyte
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Exact Sciences; Foundation Medicine; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Roche/Genentech; Samsung; Seagen
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daichii Sankyo; Pfizer; Roche/Genentech
 
Maria Vittoria Dieci
Consulting or Advisory Role - Daiichi Sankyo; Exact Sciences; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Seagen
Patents, Royalties, Other Intellectual Property - Patent pending HER2DX licensed to University of Padova